GlassScriptPhysician profile
Anthony L Dragovich
NPI 1134236763
$15,454.43
in general payments reported to CMS, 2019-2025
49 companies · $2,749 in 2025
The $2,749 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,181 · 2020: $1,804 · 2021: $1,949 · 2022: $1,742 · 2023: $2,842 · 2024: $2,186 · 2025: $2,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,777.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,319.45 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Medtronic USA, INC. | $2,703.89 | 2019-2020 | |
| Boston Scientific Corporation | $1,211.07 | 2019-2025 | Intracept, Superion Indirect Decompression System, General - Pain Management |
| Abbvie INC. | $958.46 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Pfizer INC. | $460.01 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $453.31 | 2019-2022 | |
| Abbott Laboratories | $438.35 | 2022-2025 | Proclaim, Eterna |
| Nevro Corp. | $332.14 | 2019-2024 | Senza |
| Merz Pharmaceuticals, LLC | $306.21 | 2022-2025 | Xeomin |
| Si-Bone, INC. | $241.05 | 2019-2024 | |
| Amgen INC. | $211.59 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $169.70 | 2019-2022 | |
| Depuy Synthes Sales INC. | $134.52 | 2021-2025 | Monovisc |
| Biodelivery Sciences International, INC. | $131.17 | 2019-2021 | |
| Tersera Therapeutics LLC | $121.69 | 2022-2025 | Prialt |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Dragovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.